Intelligent Bio Solutions Inc.
INBS· Nasdaq
INBSIntelligent Bio Solutions Inc.
Filed Nov 12, 2021 · 10-Q · 43 days after period end · 0001493152-21-027990
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Revenue | — | $55.43K | — |
| Net Income | -$1.43M | -$1.07M | -$764.83K |
| EPS Diluted | -$0.10 | -$0.12 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 12, 2021 · 43 d after period end
